Human intraepithelial lymphocytes (IEL), predominantly CD8+ T lymphocytes, migrate from the lamina propria to the epithelium where they reside at the basolateral aspect of epithelial cells (ECs). Here, they are capable of many types of cytotoxic activities that destroy infected or malignantly-transformed ECs. We hypothesize that abnormal EC produce chemokines that attract IELs which then lyse these abnormal ECs. The preliminary data show that IEL express a promiscuous IL-8 receptor that binds both alpha and beta chemokines, that IL-15 is more potent than any other known cytokine in inducing lymphokine-activated killer (LAK) activity, and that IL-10 and IL-12 both potentiate this activity. The first Specific Aim will examine the chemotactic response of IEL, in particular, the number and affinity of receptors of IL-8 and RANTES. The kinetics of receptor turnover and regulation will be addressed as well the mechanism of chemotaxis and chemokine secreted by ECs. The second Specific Aim will determine why IL-15 is a more potent inducer of LAK activity than IL-2 for IEL but not PBL. The number of cytokine receptors on each cell type will be determined by radioligand binding and immunofluorescence. The mechanism of action, whether mediated by perforin, Fas, or TNFalpha, the mechanism of IL-4 down- regulation of IL-15 induced LAK activity, and the potential arrest of IEL apoptosis by IL-15 will be involved. The third Specific Aim will determine how IL-10 and IL-12 increase IEL LAK activity. The phenotypes of the IEL expressing receptors for these cytokines will be determined as well as an assessment as to whether the cytokines enhanced cytotoxic activity of NK or non-NK cells. The unusual finding of IL-10 augmentation of IL-2- induced proliferation of IELs will be pursued further. These studies will determine the mechanism of IEL chemotaxis toward secreted products of ECs, why IL-15 is more potent than IL-2 in inducing LAK activity by IELs, and how IL-10 and IL-12 augment this activity.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Hamilton, Frank A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Medicine & Dentistry of NJ
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Ebert, E C (2003) Activation of human intraepithelial lymphocytes reduces CD3 expression. Clin Exp Immunol 132:424-9
Jabri, Bana; Selby, Jeanette M; Negulescu, Horia et al. (2002) TCR specificity dictates CD94/NKG2A expression by human CTL. Immunity 17:487-99
Roberts, A I; Lee, L; Schwarz, E et al. (2001) NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol 167:5527-30
Ebert, E C (2000) IL-10 enhances IL-2-induced proliferation and cytotoxicity by human intestinal lymphocytes. Clin Exp Immunol 119:426-32
Agace, W W; Amara, A; Roberts, A I et al. (2000) Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr Biol 10:325-8
Roberts, A I; Blumberg, R S; Christ, A D et al. (2000) Staphylococcal enterotoxin B induces potent cytotoxic activity by intraepithelial lymphocytes. Immunology 101:185-90
Agace, W W; Roberts, A I; Wu, L et al. (2000) Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation. Eur J Immunol 30:819-26
Zabel, B A; Agace, W W; Campbell, J J et al. (1999) Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med 190:1241-56
Ebert, E C (1999) Inhibitory effects of transforming growth factor-beta (TGF-beta) on certain functions of intraepithelial lymphocytes. Clin Exp Immunol 115:415-20
Roberts, A I; Brolin, R E; Ebert, E C (1999) Integrin alpha1beta1 (VLA-1) mediates adhesion of activated intraepithelial lymphocytes to collagen. Immunology 97:679-85

Showing the most recent 10 out of 35 publications